SEEL

Seelos Therapeutics, Inc. SEEL

Trading inactive

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode SEEL VIRI TCBP BLPH TFFP LSB KERN HSTO OSA IMTX
6M -97.25 % -98.50 % -99.38 % -76.47 % -96.81 % -51.02 % -94.97 % -93.33 % 0.00 % 60.36 %
YTD -99.79 % -98.94 % -94.85 % 0.00 % 0.00 % -82.63 % -95.93 % -93.55 % 0.00 % -5.93 %
1Y -99.82 % -99.11 % -99.80 % -81.27 % -98.87 % -78.38 % -98.22 % -93.73 % 0.00 % 84.08 %
3Y -99.99 % -99.89 % -100.00 % -99.57 % -99.97 % -99.37 % -99.99 % -99.71 % -95.27 % 17.44 %
5Y -99.99 % -99.96 % -100.00 % -99.79 % -99.95 % -99.34 % -99.99 % -99.97 % -95.12 % -14.97 %
10Y -100.00 % -99.96 % -100.00 % -99.99 % -99.95 % -99.34 % -99.99 % -100.00 % -95.12 % 2.40 %
Depuis le début -100.00 % -99.96 % -100.00 % -99.99 % -99.95 % -99.34 % -99.99 % -100.00 % -95.12 % 2.40 %

Dividende

Bellerophon Therapeutics, Inc.